P1065: CONGENITAL ERYTHROCYTOSIS DUE TO HETEROZYGOUS VARIANTS IN THE BISPHOSPHOGLYCERATE MUTASE GENE

P1065: CONGENITAL ERYTHROCYTOSIS DUE TO HETEROZYGOUS VARIANTS IN THE BISPHOSPHOGLYCERATE MUTASE GENE

Bibliographic Details
Main Authors:	M. J. van Dijk, B. A. van Oirschot, M. C. Stam-Slob, B. van der Zwaag, E. J. van Beers, J. J. Jans, P. van der Linden, J. M. Torregrosa Diaz, B. Gardie, F. Girodon, R. Schots, N. Thielen, R. van Wijk
Format:	Article
Language:	English
Published:	Wiley 2022-06-01
Series:	HemaSphere
Online Access:	http://journals.lww.com/10.1097/01.HS9.0000847128.24406.8a

Similar Items

Bisphosphoglycerate Mutase Deficiency Protects against Cerebral Malaria and Severe Malaria-Induced Anemia
by: Guoyue Xu, et al.
Published: (2020-09-01)

Placental expression of 2,3 bisphosphoglycerate mutase in IGF-II knock out mouse: correlation of circulating maternal 2,3 bisphosphoglycerate and fetal growth.
by: Gu, M, et al.
Published: (2009)

Bisphosphoglycerate mutase predicts myocardial dysfunction and adverse outcome in sepsis: an observational cohort study
by: Long Huang, et al.
Published: (2024-02-01)

The differential regulation of placenta trophoblast bisphosphoglycerate mutase in fetal growth restriction: preclinical study in mice and observational histological study of human placenta
by: Sima Stroganov, et al.
Published: (2024-02-01)

Sickling-preventive effects of rutin is associated with modulation of deoxygenated haemoglobin, 2,3-bisphosphoglycerate mutase, redox status and alteration of functional chemistry in sickle erythrocytes
by: Aliyu Muhammad, et al.
Published: (2019-06-01)

PI-05: PHARMACODYNAMIC EFFECTS OF AG-946, A HIGHLY POTENT NOVEL ACTIVATOR OF PYRUVATE KINASE, IN EX VIVO TREATMENT OF RED BLOOD CELLS FROM SICKLE CELL DISEASE PATIENTS
by: RAB M., et al.
Published: (2022-08-01)

P1492: PHARMACODYNAMIC EFFECTS OF AG-946, A HIGHLY POTENT NOVEL ACTIVATOR OF PYRUVATE KINASE, IN EX VIVO TREATMENT OF RED BLOOD CELLS FROM SICKLE CELL DISEASE PATIENTS
by: M. Rab, et al.
Published: (2022-06-01)

Germline JAK2 E846D Substitution as the Cause of Erythrocytosis?
by: Nada Maaziz, et al.
Published: (2023-05-01)

A putative 2,3-bisphosphoglycerate-dependent phosphoglycerate mutase is involved in the virulence, carbohydrate metabolism, biofilm formation, twitching halo, and osmotic tolerance in Acidovorax citrulli
by: Jongchan Lee, et al.
Published: (2022-11-01)

PI-02: FOLLOW-UP RESULTS OF A PHASE 2 STUDY ASSESSING THE SAFETY AND EFFICACY OF MITAPIVAT TREATMENT, AN ORAL PYRUVATE KINASE ACTIVATOR, FOR UP TO 60 WEEKS IN SUBJECTS WITH SICKLE CELL DISEASE
by: VAN DIJK M., et al.
Published: (2022-08-01)

Gene panel sequencing improves the diagnostic work-up of patients with idiopathic erythrocytosis and identifies new mutations
by: Camps, C, et al.
Published: (2016)

Phosphorylation-Dependent Effects on the Structural Flexibility of Phosphoglucosamine Mutase from Bacillus anthracis
by: Kyle M. Stiers, et al.
Published: (2017-11-01)

P1501: FOLLOW-UP RESULTS OF A PHASE 2 STUDY ASSESSING THE SAFETY AND EFFICACY OF MITAPIVAT TREATMENT, AN ORAL PYRUVATE KINASE ACTIVATOR, FOR UP TO 60 WEEKS IN SUBJECTS WITH SICKLE CELL DISEASE
by: M. J. van Dijk, et al.
Published: (2022-06-01)

The Complexity of Genotype-Phenotype Correlations in Hereditary Spherocytosis: A Cohort of 95 Patients
by: Annelies van Vuren, et al.
Published: (2019-08-01)

Antiretroviral activity of aminothiols, WR2721 and WR1065
by: Walker Dale M, et al.
Published: (2006-12-01)

Concentration of 2,3 bisphosphoglycerate in cattle affected with acute ruminal acidosis
by: Dhiyaa A. Moosa, et al.
Published: (2021-09-01)

Identification of a new VHL exon and complex splicing alterations in familial erythrocytosis or von Hippel-Lindau disease
by: Lenglet, M, et al.
Published: (2018)

5589320 FOLLOW-UP RESULTS OF A PHASE 2 STUDY ASSESSING THE SAFETY AND EFFICACY OF MITAPIVAT TREATMENT, AN ORAL PYRUVATE KINASE ACTIVATOR, FOR UP TO 60 WEEKS IN SUBJECTS WITH SICKLE CELL DISEASE
by: M.J. van Dijk, et al.
Published: (2023-04-01)

Interstitial lung disease with congenital erythrocytosis
by: D T Katyarmal, et al.
Published: (2022-01-01)

Surprising erythrocytosis resolution after myomectomy: myomatous erythrocytosis syndrome
by: Adriano Salaroli, et al.
Published: (2023-03-01)

PB2509: RED BLOOD CELL PYRUVATE KINASE PROPERTIES IN SICKLE CELL DISEASE – OF MICE AND MEN
by: Marissa Traets, et al.
Published: (2023-08-01)

A novel composition of endogenous metabolic modulators improves red blood cell properties in sickle cell disease
by: Myrthe J. vanDijk, et al.
Published: (2024-02-01)

A Unique Monocyte Transcriptome Discriminates Sickle Cell Disease From Other Hereditary Hemolytic Anemias and Shows the Particular Importance of Lipid and Interferon Signaling
by: Annelies J. van Vuren, et al.
Published: (2021-03-01)

P1500: 2,3-DIPHOSPHOGLYCERATE DETECTION VIA DIRECT INFUSION HIGH RESOLUTION MASS SPECTROMETRY CORRELATES WITH QUANTITATIVE DETECTION IN BLOOD OF PATIENTS WITH SICKLE CELL DISEASE
by: S. van der Veen, et al.
Published: (2022-06-01)

P-023: 2,3-DIPHOSPHOGLYCERATE DETECTION VIA DIRECT INFUSION HIGH RESOLUTION MASS SPECTROMETRY CORRELATES WITH QUANTITATIVE DETECTION IN BLOOD OF PATIENTS WITH SICKLE CELL DISEASE
by: VAN DER VEEN S., et al.
Published: (2022-08-01)

Effect of particle contact on the electrical performance of NTC-epoxy composite thermistors
by: D B Deutz, et al.
Published: (2020-01-01)

Schistosoma mansoni phosphoglycerate mutase: a glycolytic ectoenzyme with thrombolytic potential
by: Pirovich David B., et al.
Published: (2022-01-01)

What autocorrelation tells us about motor variability: insights from dart throwing.
by: Robert J van Beers, et al.
Published: (2013-01-01)

Diego Gelmírez. Los años de preparación (1065-1100)
by: Ermelindo PORTELA SILVA
Published: (2009-01-01)

Visuomotor adaptation: how forgetting keeps us conservative.
by: Katinka van der Kooij, et al.
Published: (2015-01-01)

Ektacytometry Analysis of Post-splenectomy Red Blood Cell Properties Identifies Cell Membrane Stability Test as a Novel Biomarker of Membrane Health in Hereditary Spherocytosis
by: M. C. Berrevoets, et al.
Published: (2021-03-01)

Comparing brain networks of different size and connectivity density using graph theory.
by: Bernadette C M van Wijk, et al.
Published: (2010-01-01)

P1424: ONE-YEAR FOLLOW-UP OF A PHASE 2 STUDY OF MITAPIVAT, AN ORAL PYRUVATE KINASE ACTIVATOR, FOR THE TREATMENT OF SICKLE CELL DISEASE
by: Myrthe van Dijk, et al.
Published: (2023-08-01)

Resting-state EEG oscillatory dynamics in fragile X syndrome: abnormal functional connectivity and brain network organization.
by: Melle J W van der Molen, et al.
Published: (2014-01-01)

Review on some Stefan Problems for Particle Dissolution in Solid Metallic Alloys
by: F. J. Vermolen, et al.
Published: (2005-07-01)

Exploring the BiFeO<sub>3</sub>-PbTiO<sub>3</sub>-SrTiO<sub>3</sub> Ternary System to Obtain Good Piezoelectrical Properties at Low and High Temperatures
by: Anton Tuluk, et al.
Published: (2023-10-01)

Secondary erythrocytosis in patient with acromegaly
Published: (2011-12-01)

Genetic Background of Congenital Erythrocytosis
by: Mary Frances McMullin
Published: (2021-07-01)

Structural Design and Experiments of a Dynamically Balanced Inverted Four-Bar Linkage as Manipulator Arm for High Acceleration Applications
by: Matthijs J. J. Zomerdijk, et al.
Published: (2022-05-01)

A Proposed Concept for Defective Mitophagy Leading to Late Stage Ineffective Erythropoiesis in Pyruvate Kinase Deficiency
by: Annelies Johanna van Vuren, et al.
Published: (2021-01-01)